Knowledge Center
Presentation / Oct 17, 2021
Understanding Dry Powder Inhalers Formulations: Role of Surface Polarity of lactose mixtures
Source:
AAPS 2021
Track: Formulation and Delivery – Chemical
Rapid Fire: Role of Excipients in Formulation & Drug Product Development (CE)
Ìý
Ìý Ìý |
Presenting Author:ÌýRicardo GonçalvesÌý-ÌýAnalytical Scientist, R&D Analytical Development
Ìý
Why do we use small lactose particles to improve Dry Powder Inhaler formulations? Why sieved and milled lactose particles present different properties? This presentation explores the role of surface energetics, measured using inverse gas chromatography, in the behavior of DPI formulations and the implication on their aerodynamic performance.
Ìý
Ìý
Ìý
Also in the Knowledge Center
/ Mar 10, 2021
Webinar - Development Strategies for Expediting Time-to-Market of Spray Dried Amorphous Solid Dispersions
Read more
Scientific Article
/ Feb 24, 2021
Webinar - Computational Methods and High Throughput Screening in the Formulation of ASDs
Read more
Scientific Article
/ Feb 12, 2021
Webinar - From Lab to Commercial: Fully Integrated Solutions for Dry Powder Inhalation
Read more
Scientific Article